Tele-Ophthalmology Versus Face-to-Face Retinal Consultation for Assessment of Diabetic Retinopathy in Diabetes Care Centers in India: A Multicenter Cross-Sectional Study
- PMID: 35294275
- PMCID: PMC9353985
- DOI: 10.1089/dia.2022.0025
Tele-Ophthalmology Versus Face-to-Face Retinal Consultation for Assessment of Diabetic Retinopathy in Diabetes Care Centers in India: A Multicenter Cross-Sectional Study
Abstract
Aim: To evaluate the effectiveness of tele-ophthalmology (TO) versus face-to-face screening for diabetic retinopathy (DR) in diabetes care centers (DCC) across India. Methods: This is an observational, multicenter, retrospective, cross-sectional study of DR screening in individuals with diabetes performed across 35 branches of a chain of DCC in 20 cities in India over 1 year. In 30 DCC, DR screening was performed by TO, where retinal images obtained using Fundus on Phone camera were uploaded through the telemedicine network for centralized DR grading by eight retina specialists. In five DCC, DR screening was performed by fundus examination (FE) by the same retina specialists. The rate of detection of sight-threatening DR (STDR) (defined as the presence of proliferative DR and/or diabetic macular edema) through the two modes was compared. Results: A total of 58,612 individuals were screened for DR from January 1, 2018 to December 31, 2018: 25,316 by TO and 33,296 by FE. The mean age and mean duration of diabetes of the individuals with diabetes screened by TO was 55.8 ± 11.2 years and 9.5 ± 7.3 years; and in individuals screened by FE, it was 57.5 ± 11.6 years and 11.5 ± 8.0 years respectively. The mean glycated hemoglobin was 8.8% ± 2.1% and 8.5% ± 1.9% in the two groups, respectively. Any DR was detected in 31.7% (95% confidence interval [CI]: 31.0-32.3) by tele-screening and in 38.5% (95% CI: 37.9-39.0) by FE, whereas STDR was detected in 7.3% (95% CI: 7.0-7.7) by TO and in 10.5% (95% CI: 10.2-10.9) by FE. Overall, 11.4% individuals with diabetes in the TO group, including 4.1% with ungradable images, were advised referral to retina specialists for further management. Conclusion: Screening for DR at DCC using TO is feasible and effective for STDR detection in India and may be adopted throughout India.
Keywords: Diabetes care centers; Diabetic retinopathy screening; India; Retinal imaging; Sight-threatening diabetic retinopathy; Teleophthalmology.
Conflict of interest statement
No competing financial interests exist.
Figures


Similar articles
-
Multicenter Evaluation of Diagnostic Circulating Biomarkers to Detect Sight-Threatening Diabetic Retinopathy.JAMA Ophthalmol. 2022 Jun 1;140(6):587-597. doi: 10.1001/jamaophthalmol.2022.1175. JAMA Ophthalmol. 2022. PMID: 35511139 Free PMC article.
-
Magnitude and Determinants of Diabetic Retinopathy Among Indian Diabetic Patients Undergoing Telescreening in India.Telemed J E Health. 2022 Feb;28(2):176-188. doi: 10.1089/tmj.2021.0019. Epub 2021 May 17. Telemed J E Health. 2022. PMID: 33999730
-
Wide-field imaging with smartphone based fundus camera: grading of severity of diabetic retinopathy and locating peripheral lesions in diabetic retinopathy.Eye (Lond). 2024 Jun;38(8):1471-1476. doi: 10.1038/s41433-024-02928-2. Epub 2024 Jan 31. Eye (Lond). 2024. PMID: 38297154 Free PMC article.
-
Various models for diabetic retinopathy screening that can be applied to India.Indian J Ophthalmol. 2021 Nov;69(11):2951-2958. doi: 10.4103/ijo.IJO_1145_21. Indian J Ophthalmol. 2021. PMID: 34708729 Free PMC article. Review.
-
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.Cochrane Database Syst Rev. 2023 Feb 22;2(2):CD013775. doi: 10.1002/14651858.CD013775.pub2. Cochrane Database Syst Rev. 2023. PMID: 36815723 Free PMC article. Review.
Cited by
-
Novel artificial intelligence algorithms for diabetic retinopathy and diabetic macular edema.Eye Vis (Lond). 2024 Jun 17;11(1):23. doi: 10.1186/s40662-024-00389-y. Eye Vis (Lond). 2024. PMID: 38880890 Free PMC article. Review.
-
SMART (artificial intelligence enabled) DROP (diabetic retinopathy outcomes and pathways): Study protocol for diabetic retinopathy management.PLoS One. 2025 May 19;20(5):e0324382. doi: 10.1371/journal.pone.0324382. eCollection 2025. PLoS One. 2025. PMID: 40388448 Free PMC article.
-
Diabetic retinal disease.Nat Rev Dis Primers. 2025 Aug 28;11(1):62. doi: 10.1038/s41572-025-00646-x. Nat Rev Dis Primers. 2025. PMID: 40877334 Review.
-
Creating a retinal image database to develop an automated screening tool for diabetic retinopathy in India.Sci Rep. 2025 Mar 6;15(1):7853. doi: 10.1038/s41598-025-91941-w. Sci Rep. 2025. PMID: 40050377 Free PMC article.
-
Evaluating the role of serum cystatin C as a circulating biomarker of diabetic retinopathy from a rural Indian population.Taiwan J Ophthalmol. 2024 Nov 11;14(4):573-578. doi: 10.4103/tjo.TJO-D-24-00096. eCollection 2024 Oct-Dec. Taiwan J Ophthalmol. 2024. PMID: 39803403 Free PMC article.
References
-
- Leasher JL, Bourne RR, Flaxman SR, et al. : Vision Loss Expert Group of the Global Burden of Disease Study. Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 1990 to 2010. Diabetes Care 2016;39:1643–1649. - PubMed
-
- Wong TY, Sun J, Kawasaki R, et al. : Guidelines on diabetic eye care: the international council of ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings. Ophthalmology 2018;125:1608–1622. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical